- Previous Close
20.22 - Open
20.22 - Bid 18.13 x 47300
- Ask 21.26 x 41800
- Day's Range
20.22 - 20.22 - 52 Week Range
15.62 - 21.95 - Volume
300 - Avg. Volume
13 - Market Cap (intraday)
5.913B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
35.18 - EPS (TTM)
0.60 - Earnings Date Apr 22, 2025
- Forward Dividend & Yield 0.42 (1.99%)
- Ex-Dividend Date Apr 23, 2025
- 1y Target Est
--
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
www.getinge.comRecent News: GNGBF
View MorePerformance Overview: GNGBF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GNGBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GNGBF
View MoreValuation Measures
Market Cap
5.67B
Enterprise Value
6.46B
Trailing P/E
35.17
Forward P/E
16.64
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.66
Price/Book (mrq)
1.74
Enterprise Value/Revenue
1.83
Enterprise Value/EBITDA
12.00
Financial Highlights
Profitability and Income Statement
Profit Margin
4.71%
Return on Assets (ttm)
3.94%
Return on Equity (ttm)
5.20%
Revenue (ttm)
34.76B
Net Income Avi to Common (ttm)
1.64B
Diluted EPS (ttm)
0.60
Balance Sheet and Cash Flow
Total Cash (mrq)
2.96B
Total Debt/Equity (mrq)
32.30%
Levered Free Cash Flow (ttm)
3.96B